1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
1.4 Market Analysis by Type
1.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chromosomal Abnormalities
1.4.3 X-linked Diseases
1.4.4 Freeze Embryo Testing
1.4.5 Aneuploidy Screening
1.4.6 HLA
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2021-2026
1.5.2 Stem Cell Therapy
1.5.3 IVF Prognosis
1.5.4 Late-Onset Genetic Disorders
1.5.5 Inherited Genetic Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pre-Implantation Genetic Diagnosis (PGD) Market
1.8.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Pre-Implantation Genetic Diagnosis (PGD) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Market Share by Region (2015-2020)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume
3.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume
3.4.1 East Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.5.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.6.1 South Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.7.1 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.8.1 Middle East Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.9.1 Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.10.1 Oceania Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.11.1 South America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Pre-Implantation Genetic Diagnosis (PGD) Sales Volume (2015-2020)
3.12.1 Rest of the World Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pre-Implantation Genetic Diagnosis (PGD) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Volume Market Share by Type (2015-2020)
14.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Pre-Implantation Genetic Diagnosis (PGD) Consumption Volume by Application (2015-2020)
15.2 Global Pre-Implantation Genetic Diagnosis (PGD) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Pre-Implantation Genetic Diagnosis (PGD) Business
16.1 Roche
16.1.1 Roche Company Profile
16.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 California Pacific Medical Center (CPMC)
16.2.1 California Pacific Medical Center (CPMC) Company Profile
16.2.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.2.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Illumina, Inc.
16.3.1 Illumina, Inc. Company Profile
16.3.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.3.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Genea Limited
16.4.1 Genea Limited Company Profile
16.4.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.4.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 LabCorp
16.5.1 LabCorp Company Profile
16.5.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.5.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Quest Diagnostics
16.6.1 Quest Diagnostics Company Profile
16.6.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.6.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 IGENOMIX
16.7.1 IGENOMIX Company Profile
16.7.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.7.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Cooper Medical, Inc.
16.8.1 Cooper Medical, Inc. Company Profile
16.8.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.8.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Natera, Inc.
16.9.1 Natera, Inc. Company Profile
16.9.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.9.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Thermo Fisher Scientific Inc.
16.10.1 Thermo Fisher Scientific Inc. Company Profile
16.10.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.10.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Reproductive Genetic Innovations
16.11.1 Reproductive Genetic Innovations Company Profile
16.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 CombiMatrix
16.12.1 CombiMatrix Company Profile
16.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Specification
16.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Pre-Implantation Genetic Diagnosis (PGD) Manufacturing Cost Analysis
17.1 Pre-Implantation Genetic Diagnosis (PGD) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pre-Implantation Genetic Diagnosis (PGD)
17.4 Pre-Implantation Genetic Diagnosis (PGD) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pre-Implantation Genetic Diagnosis (PGD) Distributors List
18.3 Pre-Implantation Genetic Diagnosis (PGD) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pre-Implantation Genetic Diagnosis (PGD) (2021-2026)
20.2 Global Forecasted Revenue of Pre-Implantation Genetic Diagnosis (PGD) (2021-2026)
20.3 Global Forecasted Price of Pre-Implantation Genetic Diagnosis (PGD) (2015-2026)
20.4 Global Forecasted Production of Pre-Implantation Genetic Diagnosis (PGD) by Region (2021-2026)
20.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.9 South America Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Pre-Implantation Genetic Diagnosis (PGD) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.2 East Asia Market Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.3 Europe Market Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Countriy
21.4 South Asia Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.5 Southeast Asia Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.6 Middle East Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.7 Africa Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.8 Oceania Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.9 South America Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
21.10 Rest of the world Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer